secwatch.observer — SEC 8-K summary
======================================

Issuer:     iSpecimen Inc. (ISPC)
CIK:        0001558569
Form:       8-K
Filed at:   2026-09-04T20:48:58+00:00
Accession:  0001213900-26-097726
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iSpecimen to acquire Foldlab AI assets for $4.5M; $2M cash + $2.5M stock
------------------------------------------------------------------------

- Deal: $4.5M total - $2M cash ($750K at close + $1.25M milestone payments) and $2.5M in stock.
- Assets: Disease-Associated Protein Discovery AI Agent and Disease Trend Prediction/Monitoring AI Model.
- Closing conditions: stockholder approval, Nasdaq listing approval, regulatory consents; proxy to be filed.
- Milestone payments tied to delivery/testing/acceptance; no payment for partial performance.
- Stock consideration in 5-year escrow/lock-up with no leak-out; voting rights agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1558569/000121390026097726/0001213900-26-097726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1558569/000121390026097726/ea0304738-8k_ispecimen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-097726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer